In terms of microglia function in AD, Keaney and colleagues showed that blocking BTK activity reduced PLCγ2 expression and microglial phagocytosis (Mueller et al., 2010; Keaney et al., 2019). This evidence concerns the gene BTK and Alzheimer disease.